These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34431316)

  • 1. Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives.
    Comito F; Marchese PV; Ricci AD; Tober N; Peterle C; Sperandi F; Melotti B
    Future Oncol; 2021 Nov; 17(33):4583-4606. PubMed ID: 34431316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Current State of Systemic Therapy of Metastatic Uveal Melanoma.
    Koch EAT; Heppt MV; Berking C
    Am J Clin Dermatol; 2024 Sep; 25(5):691-700. PubMed ID: 38907174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.
    Khoja L; Atenafu EG; Suciu S; Leyvraz S; Sato T; Marshall E; Keilholz U; Zimmer L; Patel SP; Piperno-Neumann S; Piulats J; Kivelä TT; Pfoehler C; Bhatia S; Huppert P; Van Iersel LBJ; De Vries IJM; Penel N; Vogl T; Cheng T; Fiorentini G; Mouriaux F; Tarhini A; Patel PM; Carvajal R; Joshua AM
    Ann Oncol; 2019 Aug; 30(8):1370-1380. PubMed ID: 31150059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic disease from uveal melanoma: treatment options and future prospects.
    Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
    Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
    Afzal MZ; Mabaera R; Shirai K
    J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
    Niederkorn A; Wackernagel W; Artl M; Schwantzer G; Aigner B; Richtig E
    Acta Ophthalmol; 2014 Dec; 92(8):e696-7. PubMed ID: 24774993
    [No Abstract]   [Full Text] [Related]  

  • 7. Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases.
    Carr MJ; Sun J; Cohen JB; Liu J; Serdiuk AA; Stewart SR; Doobay N; Duclos A; Seal DA; Choi J; Zager JS
    Cancer Control; 2020; 27(1):1073274820983019. PubMed ID: 33372814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
    Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
    Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
    [No Abstract]   [Full Text] [Related]  

  • 9. Uveal melanoma.
    Spagnolo F; Caltabiano G; Queirolo P
    Cancer Treat Rev; 2012 Aug; 38(5):549-53. PubMed ID: 22270078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy response and resistance in patients with advanced uveal melanoma: a retrospective cohort study.
    Maurer A; Clerici G; Schaab JA; Cheng PF; Mihic-Probst D; Mader C; Messerli M; Huellner MW; Dummer R; Dimitriou F
    Clin Exp Med; 2024 Oct; 24(1):234. PubMed ID: 39352553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic uveal melanoma: review and recommendations.
    Albert DM; Niffenegger AS; Willson JK
    Surv Ophthalmol; 1992; 36(6):429-38. PubMed ID: 1589858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
    Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
    Buder K; Gesierich A; Gelbrich G; Goebeler M
    Cancer Med; 2013 Oct; 2(5):674-86. PubMed ID: 24403233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tebentafusp for the treatment of metastatic uveal melanoma.
    Schank TE; Hassel JC
    Future Oncol; 2022 Apr; 18(11):1303-1311. PubMed ID: 35172589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of uveal melanoma liver metastases.
    Brasiuniene B; Sokolovas V; Brasiunas V; Barakauskiene A; Strupas K
    Eur J Med Res; 2011 Feb; 16(2):71-5. PubMed ID: 21463985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).
    Piulats JM; Espinosa E; de la Cruz Merino L; Varela M; Alonso Carrión L; Martín-Algarra S; López Castro R; Curiel T; Rodríguez-Abreu D; Redrado M; Gomà M; Rullán AJ; Calvo González A; Berrocal-Jaime A
    J Clin Oncol; 2021 Feb; 39(6):586-598. PubMed ID: 33417511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of metastatic malignant uveal melanoma].
    Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
    Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis.
    Yamada K; Takeuchi M; Fukumoto T; Suzuki M; Kato A; Mizuki Y; Yamada N; Kaneko T; Mizuki N; Horita N
    Sci Rep; 2024 Apr; 14(1):7887. PubMed ID: 38570507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study.
    Vanaken L; Woei-A-Jin FJSH; Van Ginderdeuren R; Deroose CM; Laenen A; Missotten G; Thal DR; Bechter O; Schöffski P; Clement P
    Acta Oncol; 2023 May; 62(5):480-487. PubMed ID: 37200223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.